Revisione ed aggiornamento delle linee guida sulla ... - Anmco

Ital Heart J Suppl Vol 2 Maggio 2001132. Held P, Yusuf S, Furberg C. Effects of calcium antagonistson initial infarction, reinfarction and mortality in acute myocardialinfarction and unstable angina. BMJ 1989; 299:1187-92.133. The Danish Verapamil Infarction Trial I (DAVIT I). Verapamilin acute myocardial infarction. Eur Heart J 1984; 5:516-28.134. Hansen JF. Effect of verapamil on mortality and majorevents after acute myocardial infarction (The Danish VerapamilInfarction Trial II - DAVIT II). Am J Cardiol 1990;66: 779-85.135. Boden WE, Gibson RS, Bough EW, Beller GA, SchechtmanKB, Roberts R. Effect of high-dose diltiazem on globaland regional left ventricular function during the earlycourse of acute non-Q wave myocardial infarction. AmericanJournal of Noninvasive Cardiology 1988; 2: 1-9.136. The Cardiac Arrhythmias Suppression Trial (CAST) Investigators.Increased mortality due to encainide or flecainidein a randomized trial of arrhythmia suppression after myocardialinfarction. N Engl J Med 1989; 321: 406-12.137. Teo K, Yusuf S, Furberg C. Effect of antiarrhythmic drugtherapy on mortality following myocardial infarction. (abstr)Circulation 1990; 82: III-197.138. Schwartz PJ, Camm AJ, Frangin G, et al. Does amiodaronereduce sudden death and cardiac mortality after myocardialinfarction? The European Myocardial Infarct AmiodaroneTrial (EMIAT). Eur Heart J 1994; 15: 620-4.139. Ranade W, Wolf ME, Mosnaim AD. Developments in antiarrhythmicdrugs: an overview. Expert Opin Invest Drugs1995; 4: 1101-28.140. Waldo AL, Camm AJ, DeRuyter H, et al. Survival with orald-sotalol in patients with left ventricular dysfunction aftermyocardial infarction: rationale, design, and methods (theSWORD trial). Am J Cardiol 1995; 75: 1023-7.141. Juul-Moller S, Edvardsson N, Jahnmatz B, et al. Doubleblindtrial of aspirin in primary prevention of myocardial infarctionin patients with stable chronic angina pectoris: theSwedish Angina Pectoris Aspirin Trial (SAPAT) Group.Lancet 1992; 340: 1421-5.142. Sixty-Plus Reinfarction Study Research Group. A doubleblindtrial to assess long-term oral anticoagulant therapy inelderly patients after myocardial infarction. Lancet 1980; 2:989-94.143. Smith P, Arneses H, Holme I. The effect of warfarin on mortalityand reinfarction after myocardial infarction. N Engl JMed 1990; 323: 147-52.144. Anticoagulants in the Secondary Prevention of Events inCoronary Thrombosis (ASPECT) Research Group. Effectof long-term oral anticoagulant treatment on mortality andcardiovascular morbidity after myocardial infarction.Lancet 1994; 343: 499-503.145. Coumadin Aspirin Reinfarction Study (CARS) Investigators.Randomised double-blind trial of fixed low-dose warfarinwith aspirin after myocardial infarction. Lancet 1997;350: 389-96.146. Scandinavian Simvastatin Survival Study Group. Randomisedtrial of cholesterol lowering in 4444 patients withcoronary heart disease: the Scandinavian Simvastatin SurvivalStudy (4S). Lancet 1994; 344: 1383-9.147. Sacks FM, Pfeffer MA, Moye LA, et al, for the Cholesteroland Recurrent Events Trial Investigators. The effect ofpravastatin on coronary events after myocardial infarctionin patients with average cholesterol levels. N Engl J Med1996; 335: 1001-9.148. The Long-Term Intervention with Pravastatin in IschaemicDisease (LIPID) Study Group. Prevention of cardiovascularevents and death with pravastatin in patients with coronaryheart disease and a broad base of initial cholesterol levels.N Engl J Med 1998; 339: 1349-57.149. GISSI Prevenzione Investigators. Dietary supplementationwith n-3 polyunsaturated fatty acids and vitamin E after myocardialinfarction: results of the GISSI Prevenzione trial.Lancet 1999; 354: 447-55.150. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiacrehabilitation after myocardial infarction. Combined experienceof randomized clinical trials. JAMA 1988; 260: 945-50.151. O’Connor GT, Buring JE, Yusuf S, et al. An overview ofrandomized trials of rehabilitation with exercise after myocardialinfarction. Circulation 1989; 80: 234-44.152. Bobbio M. Does post myocardial infarction rehabilitationprolong survival? A meta-analytic survey. G Ital Cardiol1989; 19: 1059-67.153. Commissione ad hoc ANMCO-SIC. Linee guida ANMCO-SIC-GIVFRC sulla riabilitazione cardiologica. G Ital Cardiol1999; 29: 1057-91.154. Working Group on Cardiac Rehabilitation of the EuropeanSociety of Cardiology. Long-term comprehensive care ofcardiac patients. Eur Heart J 1992; 13 (Suppl C): 1-45.552